-

Hello Bello Secures Future Growth with Sale to Hildred Capital Management

With new private equity ownership, Hello Bello will continue to deliver “Premium for All”

LOS ANGELES--(BUSINESS WIRE)--Hello Bello, a leading brand of premium, accessible baby and family care products, today announced that it has been acquired by Hildred Capital Management (“Hildred”), a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies.

“We are excited to be part of the Hildred family of companies,” said Erica Buxton, President of Hello Bello. “Hildred has a great deal of experience in this space and with their partnership, we are confident that we will continue to not only make great products but increase our efficiency and manufacturing capacity for our customers and retail partners. We will now be in a stronger financial position and benefit from operational expertise from both Hildred and similarly situated businesses in its portfolio.”

Hello Bello’s mission from inception has been “Premium for All,” ensuring all parents can choose the best options for their babies, no matter their budget. With the acquisition by Hildred, Hello Bello will continue to offer its award-winning premium products at affordable prices and with convenient accessibility, both in top retailers and online, throughout the United States. Hello Bello remains committed to quality, affordability, sustainability, inclusivity, and giving back.

Hildred will transition Hello Bello into its portfolio under the stewardship of Hyland’s Naturals, a Hildred portfolio company, and a leading pediatric consumer health company. With a trusted brand and rich history in the natural marketplace for over 100 years, Hyland’s Naturals offers complementary resources to accelerate Hello Bello’s growth.

Andrew Goldman, Co-Founder, Managing Partner of Hildred Capital, said, “The addition of Hello Bello to our portfolio along with Hyland’s Naturals creates one of the most significant independent pediatric platforms in the country. We look forward to making it easier than ever for parents to keep their families healthy through clean and natural product offerings.”

About Hello Bello

Hello Bello™ makes premium and high-quality baby products designed to be accessible for all families. From diapers and wipes to personal care, Hello Bello’s products are carefully crafted with babies, parents, and the planet in mind. For more information, please visit https://hellobello.com/ or follow @hellobello on Facebook, Instagram and X and @myhellobello on Pinterest.

About Hildred Capital Management

Hildred Capital Management is a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies. The Firm specializes in partnering with management teams to help them scale their platforms, generate earnings growth, promote strategic and operational improvements, generate business development, and drive multiple expansion. For more information, please visit www.hildredcapital.com and follow the Firm on LinkedIn.

About Hyland’s Naturals

Hyland’s Naturals is a leading consumer health company with more than a century of history making high quality products to help families live healthier and happier lives. With a trusted brand, Hyland’s Naturals proudly leads several consumer categories across children’s and adult’s health with over 80% of its sales from product lines that hold #1 or #2 market share in their categories. Hyland’s Naturals is headquartered in Los Angeles, CA. Follow Hyland’s Naturals on LinkedIn, Facebook, and Instagram or visit hylands.com to learn more.

Contacts

Media Contacts:

Mike Geller
Prosek Partners (on behalf of Hildred Capital)
mgeller@prosek.com

Mary Borneman
Hyland’s Naturals
mborneman@hylands.com

Hildred Capital Management Logo
Hildred Capital Management Logo

Hildred Capital Management


Release Versions

Contacts

Media Contacts:

Mike Geller
Prosek Partners (on behalf of Hildred Capital)
mgeller@prosek.com

Mary Borneman
Hyland’s Naturals
mborneman@hylands.com

More News From Hildred Capital Management

Crown Laboratories Completes Acquisition of Revance Therapeutics

NEW YORK--(BUSINESS WIRE)--Yesterday, Crown Laboratories, Inc. ("Crown"), a Hildred Capital portfolio company and privately held, global innovative leader in the skincare industry, announced the closing of its acquisition of Revance Therapeutics, Inc. ("Revance") (NASDAQ: RVNC), a biotechnology company aimed at setting the new standard in healthcare with innovative aesthetic and therapeutic offerings. Jeff Bedard, Founder and Chief Executive Officer of Crown commented, “We are excited to offici...

Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. Announce Exit from Pharmaceutics International, Inc.

NEW YORK--(BUSINESS WIRE)--A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. today announced they have exited their equity stake in Pharmaceutics International, Inc. (“Pii”), a contract development and manufacturing organization, and have closed on an undisclosed all-cash transaction to sell the company to Jabil Inc. (NYSE: JBL), a global leader in engineering, manufacturing, and supply chain solutions. Pii is a cont...

Hildred Capital Announces Oversubscribed Final Close of Hildred Equity Partners III with Capital Commitments in Excess of $800 Million

NEW YORK--(BUSINESS WIRE)--Hildred Capital Management, LLC ("Hildred"), a lower middle-market healthcare private equity firm, today announced the successful final closing of its third fund, Hildred Equity Partners III (the “Fund”). The Fund was significantly oversubscribed, exceeding its $600 million target and hitting its hard cap in seven months. With total capital commitments in excess of $800 million, the Fund represents more than double the size of its predecessor fund, Hildred Equity Part...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.